Complementing the Expanded Biopharmaceutical Platform Solution are New Charged Surface Hybrid Particle Column and GlycoWorks Kit for Glycan Preparation. Waters Corporation have reinforced its commitment to advancing biotherapeutic ...
NanoSight, leading manufacturers of unique nanoparticle characterisation technology, reports on the breakthrough cancer metastasis research of Dr Hector Peinado Selgas and Dr David Lyden's research team from Weill Cornell Medical College. ...
Tags: NanoSight, cancer metastasis, characterisation technology